Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-12-22Clinical Trial Update: Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of Seroquel SR (quetiapine extended-release) for generalized anxiety disorder has been co…
-
CLINICAL_TRIALS trial_result · 2008-12-08Clinical Trial Update: Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety [Phase 4]
Phase 4 clinical trial update reporting the completion of a study evaluating Seroquel SR (quetiapine) for alcohol use disorder with comorbid…
-
FDA approval · 2008-10-31FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved Apotex Corp's supplemental application for paroxetine hydrochloride (paroxetine HCl), confirming continued approval for the gen…
-
FDA approval · 2008-10-11FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Lexapro (escitalopram) submitted by Allergan, authorizing changes to the drug's labeling.
-
CLINICAL_TRIALS research · 2008-10-03Clinical Trial Update: Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder [NA]
Pfizer-sponsored clinical trial assessing a new scale to measure onset of action in generalized anxiety disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-08-13FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., a generic antidepressant.
-
FDA approval · 2008-07-14FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved Lannett's supplemental application for doxepin hydrochloride, confirming a generic version is approvable. The product will carr…
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited as an original application for a generic antidepressant product…
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE — Original Application (BluePoint Laboratories)
FDA approved an original application for venlafaxine from BluePoint Laboratories (venlafaxine hydrochloride) under an Abbreviated New Drug A…
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's generic venlafaxine under an original ANDA (ANDA078627). The approval adds a generic option for treating m…
-
FDA approval · 2008-05-23FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-05-20FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride/paroxetine from Zydus Lifesciences Limited, authorizing a generic parox…
-
FDA approval · 2008-05-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Vertical Pharmaceuticals, LLC)
The FDA approved a generic venlafaxine hydrochloride product (Original Application) developed by Vertical Pharmaceuticals, LLC, for the trea…
-
CLINICAL_TRIALS trial_result · 2008-04-04Clinical Trial Update: Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions [Phase 1]
Phase 1 bioavailability study of buspirone hydrochloride tablets under fasting conditions to assess bioequivalence; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-03Clinical Trial Update: A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD) [Phase 3]
A Phase 3 clinical trial evaluating PRX-00023 for generalized anxiety disorder has completed.
-
FDA approval · 2008-03-16FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for buspirone hydrochloride (generic) from Oxford Pharmaceuticals, LLC.
-
FDA approval · 2008-03-13FDA Approved: PAROXETINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved a generic paroxetine product (paroxetine hydrochloride hemihydrate) from Mylan Pharmaceuticals Inc. under an original ANDA.
-
FDA approval · 2008-02-28FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for alprazolam from Sandoz Inc, updating the regulatory status of the product.
-
FDA label_change · 2008-02-07FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-02-05FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp. to market a generic paroxetine hydrochloride product (PAROXETINE HYDROCHLORIDE).
-
FDA label_change · 2008-01-30FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) from Viatris Specialty LLC, updating the product labe…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Effects of Parental Behavior on Child Anxiety Regulation [Phase 2]
Phase 2 clinical trial update reporting completion of a study on how parental behavior influences child anxiety regulation across Separation…
-
FDA approval · 2007-12-17FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Oxford Pharmaceuticals, LLC)
FDA approved Buspirone hydrochloride as a generic drug under an Original Application by Oxford Pharmaceuticals, LLC.
-
FDA approval · 2007-12-14FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2007-11-28FDA Approved: ALPRAZOLAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Alprazolam from Hikma Pharmaceuticals USA Inc. under ANDA074312, granting regulatory clearan…